All posts by Cooley

Q3 2019 Quarterly VC Update: Anna Patterson on the State of Venture Capital Investing

In conjunction with our Q3 Venture Financing Report, I sat down with Anna Patterson from Gradient Ventures to get her take on the state of venture capital investing. Key insights On asking for help from your investor: Repeat entrepreneurs ask for help more frequently. When you need help, ask for it. That’s what […]

Q2 2019 Quarterly VC Update: Suranga Chandratillake on the State of Venture Capital Investing

In conjunction with our Q2 Venture Financing Report, Suranga Chandratillake from Balderton Capital discusses his take on the state of venture capital investing. A few highlights On technology companies driving valuations to historic highs: “Software is eating the world, and it has a voracious appetite. … Against a backdrop of sweeping technological change, the […]

Q1 2019 Quarterly VC Update: Deal Volumes and Valuations Decrease Slightly in the New Year

In conjunction with our Q1 Venture Financing Report, Zack Schildhorn from Lux Capital discusses his take on the state of venture capital investing. A few highlights On the current market: “It’s an ebullient time with plenty of cash in the ecosystem, rising valuations and – importantly – a huge wave of liquidity.” On the […]

Q4 2018 Quarterly VC Update: Hayley Barna on the State of Venture Capital Investing

In conjunction with our Q4 Venture Financing Report, Hayley Barna from First Round Capital discusses her take on the state of venture capital investing. A few highlights On the atomization of seed rounds: Often founders are raising multiple seeds – sometimes raising their institutional seed after already raising over a million dollars, whether through […]

Q3 2018 Quarterly VC Update: Bruce Booth on the State of Venture Capital Investing

In conjunction with our Q3 Venture Financing Report, Bruce Booth from Atlas Venture discusses his take on the state of venture capital investing. A few highlights On deal terms: The pendulum is definitely favoring entrepreneurs and founders, which in life sciences also typically includes venture creation-focused investors. On shifting dynamics: These trends bring life sciences […]